A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

ParcelBio, a biotechnology company developing a new class of potent and durable mRNA medicines, today announced it has raised ...

RNA modifications have emerged as a pivotal area of focus in molecular biology and precision medicine. Recent breakthroughs highlight the dynamic nature of ...

SAN DIEGO, April 15, 2026 /PRNewswire/ -- Alida Biosciences today announced the launch of its EpiPlex™ Tri-Mod™ Service, enabling simultaneous detection and quantification of three key mRNA ...

Advanced analytics and artificial intelligence (AI) will help make mRNA vaccines and therapeutics better by allowing biopharma engineers to fine-tune the enzymes used to manufacture such products.

A team of researchers led by Dr. Kim V. Narry, director of the Center for RNA Research at the Institute for Basic Science (IBS), has uncovered a key cellular mechanism that affects the function of ...

N4-Acetylation of cytidine (ac4C) is an mRNA modification that enhances cellular mRNA stability and translation. Most eukaryotic organisms catalyze ac4C using a homologue of human N-acetyltransferase ...

The EMA has recommended updating Comirnaty 10 mg formulations, including JN.1, KP.2, and LP.8.1 versions, to allow COVID-19 vaccination in individuals aged 6 months or older.

The MarketWatch News Department was not involved in the creation of this content. SAN DIEGO, April 15, 2026 /PRNewswire/ -- Alida Biosciences today announced the launch of its EpiPlex(TM) Tri-Mod(TM) ...